Weekly Digest – 18-24 Jul 2023 Weekly Digest – 18-24 Jul 2023 19 Jul 2023: KEYTRUDA (Pembrolizumab) / Newly diagnosed cervical cancer/ Merck: Phase 3 KEYNOTE-A18 trial met the primary endpoints of PFS Phase 3 KEYNOTE-A18 trial evaluating Pembro + […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id